RxDoctor Payments Data

Brandon Hagopian, DO

Family Medicine · Augusta, GANPI 1588192801

Payments from drug & device makers

$10,285in general payments, 2019–2025

Across 650 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Lilly USA, LLC$992
  • AstraZeneca$696
  • Boehringer Ingelheim$616
  • Amgen$576
  • AbbVie$563
  • plus $4K from 43 others

What the payments were for

  • Food & beverage$10,19699%
  • Education$891%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,285 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$190,409
Medicare patients
228
Services billed
15,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HetliozTasimelteon11$270,260
JardianceEmpagliflozin130$171,376
RybelsusSemaglutide72$122,138
OzempicSemaglutide52$75,904
MounjaroTirzepatide64$74,457
EliquisApixaban72$67,339
FarxigaDapagliflozin Propanediol54$63,169
TrulicityDulaglutide17$42,303
KerendiaFinerenone28$36,814
JanuviaSitagliptin Phosphate18$26,611
XareltoRivaroxaban27$24,326
Repatha SureclickEvolocumab22$23,096
VraylarCariprazine Hcl12$19,620
EntrestoSacubitril/Valsartan19$19,440
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,774

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$2,496$198,042124 claims
Boehringer IngelheimJardiance$616$171,376130 claims
Lilly USA, LLCMounjaro, Trulicity$992$116,76081 claims
PfizerEliquis$561$67,33972 claims
AstraZenecaFarxiga$696$63,16954 claims
BayerKerendia$472$36,81428 claims
GSKTrelegy Ellipta, Shingrix, Arexvy$473$36,112100 claims
MerckJanuvia$60$26,61118 claims
Johnson & JohnsonXarelto$170$24,32627 claims
AbbVieVraylar$563$19,62012 claims
NovartisEntresto$97$19,44019 claims
Astellas Pharma US IncMyrbetriq$231$10,99215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →